|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.040 AUD | -4.23% |
|
+20.00% | +23.26% |
| 11:26pm | ASX Biggest Losers | MT |
| 08-03 | ASX Biggest Gainers | MT |
Company Valuation: PYC Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 206.8 | 191.3 | 559.9 | 755.3 | 2,006 | - | - |
| Change | - | -7.47% | 192.66% | 34.9% | 165.63% | - | - |
| Enterprise Value (EV) 1 | 206.8 | 175.8 | 493.1 | 602.3 | 1,342 | 1,428 | 1,502 |
| Change | - | -15% | 180.54% | 22.15% | 122.84% | 6.37% | 5.18% |
| P/E | -14.8x | -7.89x | -12.5x | -12.9x | -30.3x | -23.1x | -25.3x |
| PBR | - | - | 5.85x | 3.82x | 2.75x | 3.68x | 3.79x |
| PEG | - | -0.1x | -0.4x | -2.75x | 1x | -0.7x | 2.93x |
| Capitalization / Revenue | - | 12x | 24.5x | 28.9x | 547x | - | 19.5x |
| EV / Revenue | - | 11x | 21.6x | 23x | 366x | - | 14.6x |
| EV / EBITDA | - | -7.83x | -13.3x | -12x | -23.1x | -14.3x | -9.26x |
| EV / EBIT | - | -7.53x | -13x | -11.8x | -22x | -14.2x | -8.65x |
| EV / FCF | - | -7.05x | -12.7x | -11.5x | -23.4x | -17.1x | -33.6x |
| FCF Yield | - | -14.2% | -7.89% | -8.72% | -4.27% | -5.86% | -2.98% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.044 | -0.071 | -0.096 | -0.1005 | -0.0702 | -0.0922 | -0.0842 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | 15.91 | 22.86 | 26.17 | 3.667 | - | 102.7 |
| EBITDA 1 | - | -22.45 | -36.99 | -50.35 | -58.03 | -99.77 | -162.2 |
| EBIT 1 | - | -23.33 | -38.06 | -50.95 | -61.1 | -100.4 | -173.6 |
| Net income 1 | -13.86 | -22.79 | -37.73 | -50.3 | -57.43 | -85.75 | -87.28 |
| Net Debt 1 | - | -15.57 | -66.87 | -153.1 | -664.3 | -578.8 | -504.8 |
| Reference price 2 | 0.650 | 0.560 | 1.200 | 1.295 | 2.130 | 2.130 | 2.130 |
| Nbr of stocks (in thousands) | 318,093 | 341,650 | 466,608 | 583,260 | 983,510 | - | - |
| Announcement Date | 8/30/22 | 8/31/23 | 8/29/24 | 8/28/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.34x | 390.17x | -24.65x | - | 1.47B | |
| 33.27x | 5.94x | 17.68x | 0.96% | 48.7B | |
| -22.15x | 304.02x | -19.9x | -.--% | 42.05B | |
| 29.93x | 2.99x | 12.91x | -.--% | 38.26B | |
| 43.85x | 4.94x | 27.58x | -.--% | 37.5B | |
| 29.67x | 8.57x | 21.53x | 0.39% | 31.44B | |
| 33.27x | 5.44x | 24.74x | -.--% | 16.33B | |
| 23.25x | 2.04x | 8.83x | 1.16% | 13.98B | |
| 53.86x | 3.78x | 14.82x | -.--% | 12.68B | |
| Average | 21.62x | 80.88x | 9.28x | 0.31% | 26.93B | |
| Weighted average by Cap. | 24.41x | 59.34x | 12.00x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PYC Stock
- Valuation PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
